Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 57 entries
Sorted by: Best Match Show Resources per page
Inactivation of bovine herpesvirus-1 and bovine viral diarrhea virus in association with preimplantation bovine embryos using photosensitive agents.

Theriogenology

Bielanski A, Dubuc C, Hare WC, Myers DJ, Eaglesome MD.
PMID: 16727166
Theriogenology. 1992 Oct;38(4):633-44. doi: 10.1016/0093-691x(92)90026-n.

Hematoporphyrin (HP), hematoporphyrin derivative (HPD), and thiopyronine (TP) are photosensitive agents (PSA) that have a germicidal effect when they are activated by light: helium neon laser (He/Ne) light (HP, HPD), white light (HP, HPD), and yellow-green light (TP). Experiments...

Cite
Bielanski A, Dubuc C, Hare WC, et al. Inactivation of bovine herpesvirus-1 and bovine viral diarrhea virus in association with preimplantation bovine embryos using photosensitive agents. Theriogenology. 1992;38(4):633-44doi: 10.1016/0093-691x(92)90026-n.
Bielanski, A., Dubuc, C., Hare, W. C., Myers, D. J., & Eaglesome, M. D. (1992). Inactivation of bovine herpesvirus-1 and bovine viral diarrhea virus in association with preimplantation bovine embryos using photosensitive agents. Theriogenology, 38(4), 633-44. https://doi.org/10.1016/0093-691x(92)90026-n
Bielanski, A, et al. "Inactivation of bovine herpesvirus-1 and bovine viral diarrhea virus in association with preimplantation bovine embryos using photosensitive agents." Theriogenology vol. 38,4 (1992): 633-44. doi: https://doi.org/10.1016/0093-691x(92)90026-n
Bielanski A, Dubuc C, Hare WC, Myers DJ, Eaglesome MD. Inactivation of bovine herpesvirus-1 and bovine viral diarrhea virus in association with preimplantation bovine embryos using photosensitive agents. Theriogenology. 1992 Oct;38(4):633-44. doi: 10.1016/0093-691x(92)90026-n. PMID: 16727166.
Copy Download .nbib Format: NLM
Photodynamic therapy of cholangiocarcinoma.

HPB : the official journal of the International Hepato Pancreato Biliary Association

Zoepf T.
PMID: 18773045
HPB (Oxford). 2008;10(3):161-3. doi: 10.1080/13651820801992625.

Photodynamic therapy (PDT) is a local photochemical tumor treatment that consists of a photosensitizing agent in combination with laser irradiation of a distinct wavelength. In some case reports and small non-randomized pilot studies, PDT has proved feasible in patients...

Cite
Zoepf T. Photodynamic therapy of cholangiocarcinoma. HPB (Oxford). 2008;10(3):161-3doi: 10.1080/13651820801992625.
Zoepf, T. (2008). Photodynamic therapy of cholangiocarcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association, 10(3), 161-3. https://doi.org/10.1080/13651820801992625
Zoepf, T. "Photodynamic therapy of cholangiocarcinoma." HPB : the official journal of the International Hepato Pancreato Biliary Association vol. 10,3 (2008): 161-3. doi: https://doi.org/10.1080/13651820801992625
Zoepf T. Photodynamic therapy of cholangiocarcinoma. HPB (Oxford). 2008;10(3):161-3. doi: 10.1080/13651820801992625. PMID: 18773045; PMCID: PMC2504366.
Copy Download .nbib Format: NLM
Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative.

International journal of antimicrobial agents

Szpakowska M, Reiss J, Graczyk A, Szmigielski S, Lasocki K, Grzybowski J.
PMID: 18611781
Int J Antimicrob Agents. 1997 Feb;8(1):23-7. doi: 10.1016/s0924-8579(96)00353-6.

The photodynamic effect of the arginine hematoporphyrin derivative (HpD-Arg(2)) on the growth of selected Pseudomonas aeruginosa clinical isolates is described as compared to the effect of hematoporphyrin derivative (HpD). Growth inhibition of HpD-Arg(2) of three Gram-positive strains (Staphylococcus aureus,...

Cite
Szpakowska M, Reiss J, Graczyk A, et al. Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative. Int J Antimicrob Agents. 1997;8(1):23-7doi: 10.1016/s0924-8579(96)00353-6.
Szpakowska, M., Reiss, J., Graczyk, A., Szmigielski, S., Lasocki, K., & Grzybowski, J. (1997). Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative. International journal of antimicrobial agents, 8(1), 23-7. https://doi.org/10.1016/s0924-8579(96)00353-6
Szpakowska, M, et al. "Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative." International journal of antimicrobial agents vol. 8,1 (1997): 23-7. doi: https://doi.org/10.1016/s0924-8579(96)00353-6
Szpakowska M, Reiss J, Graczyk A, Szmigielski S, Lasocki K, Grzybowski J. Susceptibility of Pseudomonas aeruginosa to a photodynamic effect of the arginine hematoporphyrin derivative. Int J Antimicrob Agents. 1997 Feb;8(1):23-7. doi: 10.1016/s0924-8579(96)00353-6. PMID: 18611781.
Copy Download .nbib Format: NLM
Tumor detection in mice by measurement of fluorescence decay time matrices.

Applied optics

Cubeddu R, Pifferi A, Taroni P, Valentini G, Canti G.
PMID: 20372337
Appl Opt. 1981 Dec 15;20(24):2553-5.

An intensified CCD video camera has been used to measure the spatial distribution of the fluorescence decay time in tumor-bearing mice sensitized with hematoporphyrin derivative. Mice were injected with five doses of sensitizer, ranging from 0.1 to 10 mg/kg...

Cite
Cubeddu R, Pifferi A, Taroni P, et al. Tumor detection in mice by measurement of fluorescence decay time matrices. Appl Opt. 1981;20(24):2553-5
Cubeddu, R., Pifferi, A., Taroni, P., Valentini, G., & Canti, G. (1981). Tumor detection in mice by measurement of fluorescence decay time matrices. Applied optics, 20(24), 2553-5.
Cubeddu, R, et al. "Tumor detection in mice by measurement of fluorescence decay time matrices." Applied optics vol. 20,24 (1981): 2553-5.
Cubeddu R, Pifferi A, Taroni P, Valentini G, Canti G. Tumor detection in mice by measurement of fluorescence decay time matrices. Appl Opt. 1981 Dec 15;20(24):2553-5. PMID: 20372337.
Copy Download .nbib Format: NLM
Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study.

Photodiagnosis and photodynamic therapy

Wang D, Wang P, Li C, Zhou Z, Zhang L, Zhang G, Wang X.
PMID: 34883272
Photodiagnosis Photodyn Ther. 2021 Dec 07;37:102670. doi: 10.1016/j.pdpdt.2021.102670. Epub 2021 Dec 07.

BACKGROUND: Extramammary Paget's Disease (EMPD) is an intraepithelial cancer that is prone to recurrence and sometimes refractory to therapy. A few EMPD cases have been treated with Photodynamic therapy (PDT), which reported high complete remission (CR) rates and low...

Cite
Wang D, Wang P, Li C, et al. Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis Photodyn Ther. 2021;37:102670doi: 10.1016/j.pdpdt.2021.102670.
Wang, D., Wang, P., Li, C., Zhou, Z., Zhang, L., Zhang, G., & Wang, X. (2021). Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis and photodynamic therapy, 37102670. https://doi.org/10.1016/j.pdpdt.2021.102670
Wang, Dixin, et al. "Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study." Photodiagnosis and photodynamic therapy vol. 37 (2021): 102670. doi: https://doi.org/10.1016/j.pdpdt.2021.102670
Wang D, Wang P, Li C, Zhou Z, Zhang L, Zhang G, Wang X. Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis Photodyn Ther. 2021 Dec 07;37:102670. doi: 10.1016/j.pdpdt.2021.102670. Epub 2021 Dec 07. PMID: 34883272.
Copy Download .nbib Format: NLM
Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study.

Photodiagnosis and photodynamic therapy

Wang D, Wang P, Li C, Zhou Z, Zhang L, Zhang G, Wang X.
PMID: 34883272
Photodiagnosis Photodyn Ther. 2021 Dec 07;37:102670. doi: 10.1016/j.pdpdt.2021.102670. Epub 2021 Dec 07.

BACKGROUND: Extramammary Paget's Disease (EMPD) is an intraepithelial cancer that is prone to recurrence and sometimes refractory to therapy. A few EMPD cases have been treated with Photodynamic therapy (PDT), which reported high complete remission (CR) rates and low...

Cite
Wang D, Wang P, Li C, et al. Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis Photodyn Ther. 2021;37:102670doi: 10.1016/j.pdpdt.2021.102670.
Wang, D., Wang, P., Li, C., Zhou, Z., Zhang, L., Zhang, G., & Wang, X. (2021). Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis and photodynamic therapy, 37102670. https://doi.org/10.1016/j.pdpdt.2021.102670
Wang, Dixin, et al. "Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study." Photodiagnosis and photodynamic therapy vol. 37 (2021): 102670. doi: https://doi.org/10.1016/j.pdpdt.2021.102670
Wang D, Wang P, Li C, Zhou Z, Zhang L, Zhang G, Wang X. Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis Photodyn Ther. 2021 Dec 07;37:102670. doi: 10.1016/j.pdpdt.2021.102670. Epub 2021 Dec 07. PMID: 34883272.
Copy Download .nbib Format: NLM
Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study.

Photodiagnosis and photodynamic therapy

Wang D, Wang P, Li C, Zhou Z, Zhang L, Zhang G, Wang X.
PMID: 34883272
Photodiagnosis Photodyn Ther. 2021 Dec 07;37:102670. doi: 10.1016/j.pdpdt.2021.102670. Epub 2021 Dec 07.

BACKGROUND: Extramammary Paget's Disease (EMPD) is an intraepithelial cancer that is prone to recurrence and sometimes refractory to therapy. A few EMPD cases have been treated with Photodynamic therapy (PDT), which reported high complete remission (CR) rates and low...

Cite
Wang D, Wang P, Li C, et al. Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis Photodyn Ther. 2021;37:102670doi: 10.1016/j.pdpdt.2021.102670.
Wang, D., Wang, P., Li, C., Zhou, Z., Zhang, L., Zhang, G., & Wang, X. (2021). Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis and photodynamic therapy, 37102670. https://doi.org/10.1016/j.pdpdt.2021.102670
Wang, Dixin, et al. "Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study." Photodiagnosis and photodynamic therapy vol. 37 (2021): 102670. doi: https://doi.org/10.1016/j.pdpdt.2021.102670
Wang D, Wang P, Li C, Zhou Z, Zhang L, Zhang G, Wang X. Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis Photodyn Ther. 2021 Dec 07;37:102670. doi: 10.1016/j.pdpdt.2021.102670. Epub 2021 Dec 07. PMID: 34883272.
Copy Download .nbib Format: NLM
Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a single-institution experience.

Diagnostic and therapeutic endoscopy

Radu A, Grosjean P, Fontolliet C, Wagnieres G, Woodtli A, Bergh HV, Monnier P.
PMID: 18493496
Diagn Ther Endosc. 1999;5(3):145-54. doi: 10.1155/DTE.5.145.

Cancer, when detected at an early stage, has a very good probability of being eradicated by surgery or radiotherapy. However, less aggressive treatments also tend to provide high rates of cure without the side effects of radical therapy. We...

Cite
Radu A, Grosjean P, Fontolliet C, et al. Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a single-institution experience. Diagn Ther Endosc. 1999;5(3):145-54doi: 10.1155/DTE.5.145.
Radu, A., Grosjean, P., Fontolliet, C., Wagnieres, G., Woodtli, A., Bergh, H. V., & Monnier, P. (1999). Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a single-institution experience. Diagnostic and therapeutic endoscopy, 5(3), 145-54. https://doi.org/10.1155/DTE.5.145
Radu, A, et al. "Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a single-institution experience." Diagnostic and therapeutic endoscopy vol. 5,3 (1999): 145-54. doi: https://doi.org/10.1155/DTE.5.145
Radu A, Grosjean P, Fontolliet C, Wagnieres G, Woodtli A, Bergh HV, Monnier P. Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a single-institution experience. Diagn Ther Endosc. 1999;5(3):145-54. doi: 10.1155/DTE.5.145. PMID: 18493496; PMCID: PMC2362631.
Copy Download .nbib Format: NLM
Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study.

Photodiagnosis and photodynamic therapy

Wang D, Wang P, Li C, Zhou Z, Zhang L, Zhang G, Wang X.
PMID: 34883272
Photodiagnosis Photodyn Ther. 2021 Dec 07;37:102670. doi: 10.1016/j.pdpdt.2021.102670. Epub 2021 Dec 07.

BACKGROUND: Extramammary Paget's Disease (EMPD) is an intraepithelial cancer that is prone to recurrence and sometimes refractory to therapy. A few EMPD cases have been treated with Photodynamic therapy (PDT), which reported high complete remission (CR) rates and low...

Cite
Wang D, Wang P, Li C, et al. Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis Photodyn Ther. 2021;37:102670doi: 10.1016/j.pdpdt.2021.102670.
Wang, D., Wang, P., Li, C., Zhou, Z., Zhang, L., Zhang, G., & Wang, X. (2021). Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis and photodynamic therapy, 37102670. https://doi.org/10.1016/j.pdpdt.2021.102670
Wang, Dixin, et al. "Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study." Photodiagnosis and photodynamic therapy vol. 37 (2021): 102670. doi: https://doi.org/10.1016/j.pdpdt.2021.102670
Wang D, Wang P, Li C, Zhou Z, Zhang L, Zhang G, Wang X. Efficacy and safety of HpD-PDT for Extramammary Paget's Disease refractory to conventional therapy: A prospective, open-label and single arm pilot study. Photodiagnosis Photodyn Ther. 2021 Dec 07;37:102670. doi: 10.1016/j.pdpdt.2021.102670. Epub 2021 Dec 07. PMID: 34883272.
Copy Download .nbib Format: NLM
[Effects of photodynamic therapy on human lung adenocarcinoma cell line A549].

Zhongguo fei ai za zhi = Chinese journal of lung cancer

Sun Y, Li Q, Yao X, Liu Z.
PMID: 21244790
Zhongguo Fei Ai Za Zhi. 2004 Oct 20;7(5):396-8. doi: 10.3779/j.issn.1009-3419.2004.05.05.

BACKGROUND: To observe the effects of photodynamic therapy (PDT) on human lung adenocarcinoma cell line A549 in vitro.METHODS: Human lung adenocarcinoma cell line A549 was used to investigate the killing role of PDT with hematoporphyrin derivative (HPD) as photosensitizer...

Cite
Sun Y, Li Q, Yao X, et al. [Effects of photodynamic therapy on human lung adenocarcinoma cell line A549]. Zhongguo Fei Ai Za Zhi. 2004;7(5):396-8doi: 10.3779/j.issn.1009-3419.2004.05.05.
Sun, Y., Li, Q., Yao, X., & Liu, Z. (2004). [Effects of photodynamic therapy on human lung adenocarcinoma cell line A549]. Zhongguo fei ai za zhi = Chinese journal of lung cancer, 7(5), 396-8. https://doi.org/10.3779/j.issn.1009-3419.2004.05.05
Sun, Yanni, et al. "[Effects of photodynamic therapy on human lung adenocarcinoma cell line A549]." Zhongguo fei ai za zhi = Chinese journal of lung cancer vol. 7,5 (2004): 396-8. doi: https://doi.org/10.3779/j.issn.1009-3419.2004.05.05
Sun Y, Li Q, Yao X, Liu Z. [Effects of photodynamic therapy on human lung adenocarcinoma cell line A549]. Zhongguo Fei Ai Za Zhi. 2004 Oct 20;7(5):396-8. doi: 10.3779/j.issn.1009-3419.2004.05.05. Chinese. PMID: 21244790.
Copy Download .nbib Format: NLM
Quantification of the hematoporphyrin derivative by fluorescence measurementusing dual-wavelength excitation anddual-wavelength detection.

Applied optics

Sinaasappel M, Sterenborg HJ.
PMID: 20802722
Appl Opt. 1993 Feb 01;32(4):541-8. doi: 10.1364/AO.32.000541.

A theory is presented describing a method for quantitative measurement of fluorophores in vivo. The method employs a combination of two-wavelength excitation and two-wavelength detection. A dimensionless fluorescence ratio is defined. The theory predicts that this ratio is a...

Cite
Sinaasappel M, Sterenborg HJ. Quantification of the hematoporphyrin derivative by fluorescence measurementusing dual-wavelength excitation anddual-wavelength detection. Appl Opt. 1993;32(4):541-8doi: 10.1364/AO.32.000541.
Sinaasappel, M., & Sterenborg, H. J. (1993). Quantification of the hematoporphyrin derivative by fluorescence measurementusing dual-wavelength excitation anddual-wavelength detection. Applied optics, 32(4), 541-8. https://doi.org/10.1364/AO.32.000541
Sinaasappel, M, and Sterenborg, H J. "Quantification of the hematoporphyrin derivative by fluorescence measurementusing dual-wavelength excitation anddual-wavelength detection." Applied optics vol. 32,4 (1993): 541-8. doi: https://doi.org/10.1364/AO.32.000541
Sinaasappel M, Sterenborg HJ. Quantification of the hematoporphyrin derivative by fluorescence measurementusing dual-wavelength excitation anddual-wavelength detection. Appl Opt. 1993 Feb 01;32(4):541-8. doi: 10.1364/AO.32.000541. PMID: 20802722.
Copy Download .nbib Format: NLM
Study of cell killing and morphology on S180 by ultrasound activating hematoporphyrin derivatives.

Science in China. Series C, Life sciences

Liu Q, Sun S, Xiao Y, Qi H, Shang Z, Zhang J, Zhang J, Ren Y, Li M, Li Q.
PMID: 18763140
Sci China C Life Sci. 2003 Jun;46(3):253-62. doi: 10.1360/03yc9027.

The inhibition of ascitic S180 and induced sarcoma 180 in vivo was studied with the combination of hematoporphyrin derivatives (HpD) and ultrasound (US) at the frequency of 1.1 MHz and different intensities by light microscopy observation, electronic microscopy observation,...

Cite
Liu Q, Sun S, Xiao Y, et al. Study of cell killing and morphology on S180 by ultrasound activating hematoporphyrin derivatives. Sci China C Life Sci. 2003;46(3):253-62doi: 10.1360/03yc9027.
Liu, Q., Sun, S., Xiao, Y., Qi, H., Shang, Z., Zhang, J., Zhang, J., Ren, Y., Li, M., & Li, Q. (2003). Study of cell killing and morphology on S180 by ultrasound activating hematoporphyrin derivatives. Science in China. Series C, Life sciences, 46(3), 253-62. https://doi.org/10.1360/03yc9027
Liu, Quanhong, et al. "Study of cell killing and morphology on S180 by ultrasound activating hematoporphyrin derivatives." Science in China. Series C, Life sciences vol. 46,3 (2003): 253-62. doi: https://doi.org/10.1360/03yc9027
Liu Q, Sun S, Xiao Y, Qi H, Shang Z, Zhang J, Zhang J, Ren Y, Li M, Li Q. Study of cell killing and morphology on S180 by ultrasound activating hematoporphyrin derivatives. Sci China C Life Sci. 2003 Jun;46(3):253-62. doi: 10.1360/03yc9027. PMID: 18763140.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 57 entries